AAPL347.86-0.37 (-0.10%) ▼|ABBV285.28+0.09 (+0.03%) ▲|ABT102.99+0.48 (+0.47%) ▲|ACN247.30-11.44 (-4.42%) ▼|ADBE264.70-5.85 (-2.16%) ▼|AMAT382.35+6.77 (+1.80%) ▲|AMD518.40+10.47 (+2.06%) ▲|AMGN442.41-4.87 (-1.09%) ▼|AMT189.80+8.23 (+4.53%) ▲|AMZN249.56-0.82 (-0.33%) ▼|AVGO325.34+2.10 (+0.65%) ▲|AXP313.32-11.85 (-3.64%) ▼|BA186.84-0.72 (-0.38%) ▼|BAC50.79-0.29 (-0.57%) ▼|BKNG156.79-4.31 (-2.68%) ▼|BLK1,121.03-16.26 (-1.43%) ▼|BMY61.73-1.27 (-2.02%) ▼|BNY145.21-0.12 (-0.08%) ▼|BRK-B544.61-2.36 (-0.43%) ▼|C121.01-1.50 (-1.22%) ▼|CAT689.05-15.00 (-2.13%) ▼|CL94.15-3.24 (-3.33%) ▼|CMCSA22.71-0.14 (-0.59%) ▼|COF201.07-2.36 (-1.16%) ▼|COP152.43+6.80 (+4.67%) ▲|COST1,007.27-10.94 (-1.07%) ▼|CRM245.43-4.86 (-1.94%) ▼|CSCO106.52+1.63 (+1.55%) ▲|CVS93.67-0.81 (-0.86%) ▼|CVX232.96+6.28 (+2.77%) ▲|DE645.04+1.42 (+0.22%) ▲|DHR225.92-3.84 (-1.67%) ▼|DIS112.79-0.34 (-0.30%) ▼|DUK124.61-0.79 (-0.63%) ▼|EMR161.41+1.12 (+0.70%) ▲|FDX298.81-5.11 (-1.68%) ▼|GD348.42-2.38 (-0.68%) ▼|GE286.43-7.11 (-2.42%) ▼|GEV825.86-1.57 (-0.19%) ▼|GILD156.94-0.25 (-0.16%) ▼|GM75.54-1.67 (-2.16%) ▼|GOOG320.45-0.31 (-0.10%) ▼|GOOGL323.61-0.62 (-0.19%) ▼|GS885.04-6.26 (-0.70%) ▼|HD319.01-8.72 (-2.66%) ▼|HON219.15+0.84 (+0.38%) ▲|IBM252.62+0.51 (+0.20%) ▲|INTC87.06+1.57 (+1.84%) ▲|INTU345.79-9.11 (-2.57%) ▼|ISRG456.87+13.02 (+2.93%) ▲|JNJ262.87-4.75 (-1.77%) ▼|JPM332.01-4.53 (-1.35%) ▼|KO93.28-2.07 (-2.17%) ▼|LIN510.41+0.05 (+0.01%) ▲|LLY1,282.45-24.24 (-1.86%) ▼|LMT597.36+7.45 (+1.26%) ▲|LOW198.63-5.75 (-2.81%) ▼|LRCX233.12+2.97 (+1.29%) ▲|MA622.00-11.22 (-1.77%) ▼|MCD247.86-4.77 (-1.89%) ▼|MDLZ63.63-1.56 (-2.39%) ▼|MDT96.12-0.47 (-0.49%) ▼|META645.93-2.92 (-0.45%) ▼|MMM174.02-1.54 (-0.88%) ▼|MO74.96-1.11 (-1.46%) ▼|MRK144.97-2.27 (-1.54%) ▼|MS181.42-2.55 (-1.39%) ▼|MSFT524.63+3.55 (+0.68%) ▲|MU885.55+29.06 (+3.39%) ▲|NEE81.90-0.01 (-0.01%) ▼|NFLX67.02-0.04 (-0.05%) ▼|NKE37.68-0.65 (-1.68%) ▼|NOW156.83-0.17 (-0.11%) ▼|NVDA212.30+0.09 (+0.04%) ▲|ORCL127.44+1.90 (+1.51%) ▲|PEP135.08-3.75 (-2.70%) ▼|PFE30.10-0.33 (-1.07%) ▼|PG161.17-3.34 (-2.03%) ▼|PLTR195.88-0.32 (-0.16%) ▼|PM200.57-1.17 (-0.58%) ▼|QCOM174.86+2.03 (+1.17%) ▲|RTX191.21-3.50 (-1.80%) ▼|SBUX101.04-0.87 (-0.85%) ▼|SCHW90.24-1.20 (-1.31%) ▼|SO93.12-0.70 (-0.75%) ▼|SPG211.38-0.67 (-0.31%) ▼|T21.47-1.28 (-5.61%) ▼|TMO667.19-9.36 (-1.38%) ▼|TMUS150.15-8.64 (-5.44%) ▼|TSLA372.04-2.54 (-0.68%) ▼|TXN285.04+5.54 (+1.98%) ▲|UBER67.84-1.23 (-1.78%) ▼|UNH423.36-1.63 (-0.38%) ▼|UNP293.49-4.60 (-1.54%) ▼|UPS100.67-0.86 (-0.84%) ▼|USB59.61-0.42 (-0.69%) ▼|V408.98-5.36 (-1.29%) ▼|VZ44.57-0.64 (-1.40%) ▼|WFC82.45-0.56 (-0.67%) ▼|WMT119.96-1.16 (-0.96%) ▼|XOM183.02+4.79 (+2.69%) ▲|AAPL347.86-0.37 (-0.10%) ▼|ABBV285.28+0.09 (+0.03%) ▲|ABT102.99+0.48 (+0.47%) ▲|ACN247.30-11.44 (-4.42%) ▼|ADBE264.70-5.85 (-2.16%) ▼|AMAT382.35+6.77 (+1.80%) ▲|AMD518.40+10.47 (+2.06%) ▲|AMGN442.41-4.87 (-1.09%) ▼|AMT189.80+8.23 (+4.53%) ▲|AMZN249.56-0.82 (-0.33%) ▼|AVGO325.34+2.10 (+0.65%) ▲|AXP313.32-11.85 (-3.64%) ▼|BA186.84-0.72 (-0.38%) ▼|BAC50.79-0.29 (-0.57%) ▼|BKNG156.79-4.31 (-2.68%) ▼|BLK1,121.03-16.26 (-1.43%) ▼|BMY61.73-1.27 (-2.02%) ▼|BNY145.21-0.12 (-0.08%) ▼|BRK-B544.61-2.36 (-0.43%) ▼|C121.01-1.50 (-1.22%) ▼|CAT689.05-15.00 (-2.13%) ▼|CL94.15-3.24 (-3.33%) ▼|CMCSA22.71-0.14 (-0.59%) ▼|COF201.07-2.36 (-1.16%) ▼|COP152.43+6.80 (+4.67%) ▲|COST1,007.27-10.94 (-1.07%) ▼|CRM245.43-4.86 (-1.94%) ▼|CSCO106.52+1.63 (+1.55%) ▲|CVS93.67-0.81 (-0.86%) ▼|CVX232.96+6.28 (+2.77%) ▲|DE645.04+1.42 (+0.22%) ▲|DHR225.92-3.84 (-1.67%) ▼|DIS112.79-0.34 (-0.30%) ▼|DUK124.61-0.79 (-0.63%) ▼|EMR161.41+1.12 (+0.70%) ▲|FDX298.81-5.11 (-1.68%) ▼|GD348.42-2.38 (-0.68%) ▼|GE286.43-7.11 (-2.42%) ▼|GEV825.86-1.57 (-0.19%) ▼|GILD156.94-0.25 (-0.16%) ▼|GM75.54-1.67 (-2.16%) ▼|GOOG320.45-0.31 (-0.10%) ▼|GOOGL323.61-0.62 (-0.19%) ▼|GS885.04-6.26 (-0.70%) ▼|HD319.01-8.72 (-2.66%) ▼|HON219.15+0.84 (+0.38%) ▲|IBM252.62+0.51 (+0.20%) ▲|INTC87.06+1.57 (+1.84%) ▲|INTU345.79-9.11 (-2.57%) ▼|ISRG456.87+13.02 (+2.93%) ▲|JNJ262.87-4.75 (-1.77%) ▼|JPM332.01-4.53 (-1.35%) ▼|KO93.28-2.07 (-2.17%) ▼|LIN510.41+0.05 (+0.01%) ▲|LLY1,282.45-24.24 (-1.86%) ▼|LMT597.36+7.45 (+1.26%) ▲|LOW198.63-5.75 (-2.81%) ▼|LRCX233.12+2.97 (+1.29%) ▲|MA622.00-11.22 (-1.77%) ▼|MCD247.86-4.77 (-1.89%) ▼|MDLZ63.63-1.56 (-2.39%) ▼|MDT96.12-0.47 (-0.49%) ▼|META645.93-2.92 (-0.45%) ▼|MMM174.02-1.54 (-0.88%) ▼|MO74.96-1.11 (-1.46%) ▼|MRK144.97-2.27 (-1.54%) ▼|MS181.42-2.55 (-1.39%) ▼|MSFT524.63+3.55 (+0.68%) ▲|MU885.55+29.06 (+3.39%) ▲|NEE81.90-0.01 (-0.01%) ▼|NFLX67.02-0.04 (-0.05%) ▼|NKE37.68-0.65 (-1.68%) ▼|NOW156.83-0.17 (-0.11%) ▼|NVDA212.30+0.09 (+0.04%) ▲|ORCL127.44+1.90 (+1.51%) ▲|PEP135.08-3.75 (-2.70%) ▼|PFE30.10-0.33 (-1.07%) ▼|PG161.17-3.34 (-2.03%) ▼|PLTR195.88-0.32 (-0.16%) ▼|PM200.57-1.17 (-0.58%) ▼|QCOM174.86+2.03 (+1.17%) ▲|RTX191.21-3.50 (-1.80%) ▼|SBUX101.04-0.87 (-0.85%) ▼|SCHW90.24-1.20 (-1.31%) ▼|SO93.12-0.70 (-0.75%) ▼|SPG211.38-0.67 (-0.31%) ▼|T21.47-1.28 (-5.61%) ▼|TMO667.19-9.36 (-1.38%) ▼|TMUS150.15-8.64 (-5.44%) ▼|TSLA372.04-2.54 (-0.68%) ▼|TXN285.04+5.54 (+1.98%) ▲|UBER67.84-1.23 (-1.78%) ▼|UNH423.36-1.63 (-0.38%) ▼|UNP293.49-4.60 (-1.54%) ▼|UPS100.67-0.86 (-0.84%) ▼|USB59.61-0.42 (-0.69%) ▼|V408.98-5.36 (-1.29%) ▼|VZ44.57-0.64 (-1.40%) ▼|WFC82.45-0.56 (-0.67%) ▼|WMT119.96-1.16 (-0.96%) ▼|XOM183.02+4.79 (+2.69%) ▲|
13.2 C
New York
Friday, October 23, 2026

Tag: drug

newsFORsourcecompanycontentinformation1releasesmarket

£7.5 million Longitude Prize on ALS launches

LONDON, June 25, 2025 /CNW/ -- The Longitude Prize on ALS, a £7.5 million global challenge prize, has launched to incentivise and reward cutting...

Novo Nordisk Foundation and University of Copenhagen announce USD 109 million grant to new Danish research centre to make designed proteins with vast potential

COPENHAGEN, Denmark, June 25, 2025 /PRNewswire/ -- Designed proteins are anticipated to have groundbreaking impact on a range of issues from treating disease to...

Novo Nordisk Foundation and University of Copenhagen announce USD 109 million grant to new Danish research centre to make designed proteins with vast potential

COPENHAGEN, Denmark, June 25, 2025 /PRNewswire/ -- Designed proteins are anticipated to have groundbreaking impact on a range of issues from treating disease to...

Hewelth BioClear Launches as Breakthrough In-Home Laser Solution to Support Healthier Nail Appearance

Dermatologist-Endorsed Low-Level Laser Device Introduced to Enhance Nail Appearance Through Non-Invasive At-Home Use 
Dermatologist-Endorsed Low-Level Laser Device Introduced to Enhance Nail Appearance Through Non-Invasive At-Home Use

Cidara Announces Pricing of Upsized Public Offering of Common Stock

SAN DIEGO, June 24, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (“Cidara”) (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced the pricing of an underwritten public offering of 7,954,546 shares of its common stock at a price to the public of $44.00 per share. All of the shares are to be sold by Cidara.

BAFF- and APRIL-targeted Therapies Market Sees Surge in Activity Amid Rising Autoimmune Disease Burden | DelveInsight

The BAFF- and APRIL-targeted therapies market is experiencing steady growth driven by the rising prevalence of autoimmune diseases such as systemic lupus erythematosus (SLE),...

BAFF- and APRIL-targeted Therapies Market Sees Surge in Activity Amid Rising Autoimmune Disease Burden | DelveInsight

The BAFF- and APRIL-targeted therapies market is experiencing steady growth driven by the rising prevalence of autoimmune diseases such as systemic lupus erythematosus (SLE),...

SciSparc Announces 1-for-21 Reverse Share Split

Following the reverse share split, the Company will have approximately 534,600 outstanding shares, out of which approximately 516,727 will be publicly held 
Following the reverse share split, the Company will have approximately 534,600 outstanding shares, out of which approximately 516,727 will be publicly held

Cue Biopharma Receives FDA Feedback on Pre-IND Briefing Document Reinforcing Company’s Intention to Advance IND Submission for CUE-401 to Address Unmet Need in the...

CUE-401, a first-in-class bispecific molecule designed to induce and expand Tregs in vivo through the co-activity of transforming TGF-β and a modified variant of IL-2 
CUE-401, a first-in-class bispecific molecule designed to induce and expand Tregs in vivo through the co-activity of transforming TGF-β and a modified variant of IL-2

TerrAscend Announces Results of Annual General Meeting

 

June is Men’s Health Month; Daily Skincare is part of Year-Round Health for Men

IRVINE, Calif., June 24, 2025 /PRNewswire/ -- "At Arbonne, we believe skincare is health care, and it's just as important for men as for...

Nano Earth Labs Keto ACV Gummies Website Update Introduces Consumer Tools for Daily Ketogenic Supplementation Support

Nano Earth Labs Keto ACV Gummies featured in updated official website rollout with consumer tools, subscription options, and ketogenic support information. 
Nano Earth Labs Keto ACV Gummies featured in updated official website rollout with consumer tools, subscription options, and ketogenic support information.

Five University of Colorado Cancer Center Advancements That Changed the Game for Patients

As the CU Cancer Center celebrates its 40th anniversary, here are five ways it helped to change detection and treatment of the disease. AURORA, Colo.,...

Wall Street Eyes Breakout Cancer Therapies Amid Soaring Drug Prices

Equity Insider News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, June 24, 2025 /PRNewswire/ -- Equity Insider News Commentary – Rising rates of cancer...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsDrug

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers